PharmaShots | Incisive News in 3 Shots

Subscribe Now

201 Study

Eisai Presents Results of Lecanemab in P-IIb Study 201 Study for the Treatment of Alzheimer's Disease at CTAD 2021

Eisai Presents Results of Lecanemab in P-IIb Study 201 Study for the Treatment of Alzheimer's Disease at CTAD 2021

November 12, 2021

Biogen and Eisai Report Results of Lecanemab (BAN2401) in P-IIb Study 201 for Patients with Early Alzheimer Disease

Biogen and Eisai Report Results of Lecanemab (BAN2401) in P-IIb Study 201 for Patients with Early Alzheimer Disease

April 20, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us